{
  "id": "8da80a2198c2f756",
  "title": "Best Tirzepatide Access Pathways for 2026 : FDA Regulatory Changes , Insurance Coverage Shifts , and Cash - Pay Options Explained",
  "description": "20251231T104500Z",
  "content": "",
  "source": "portal.sina.com.hk",
  "source_url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/12/31/1424296/best-tirzepatide-access-pathways-for-2026-fda-regulatory-changes-insurance-coverage-shifts-and-cash-pay-options-explained/",
  "published_at": "20251231T104500Z",
  "fetched_at": "2026-01-01T00:26:23.010909+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "regulatory",
    "ai"
  ],
  "location": "Hong Kong",
  "raw_data": {
    "url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/12/31/1424296/best-tirzepatide-access-pathways-for-2026-fda-regulatory-changes-insurance-coverage-shifts-and-cash-pay-options-explained/",
    "url_mobile": "",
    "title": "Best Tirzepatide Access Pathways for 2026 : FDA Regulatory Changes , Insurance Coverage Shifts , and Cash - Pay Options Explained",
    "seendate": "20251231T104500Z",
    "socialimage": "https://fixedagency.com/wp-content/uploads/2025/12/Best-Tirzepatide-Access-Pathways-for-2026_-FDA-Regulatory-Changes-Insurance-Coverage-Shifts-and-Cash-Pay-Options-Explained.jpg",
    "domain": "portal.sina.com.hk",
    "language": "English",
    "sourcecountry": "Hong Kong"
  }
}